Ultragenyx Pharmaceutical
RARE
#5107
Rank
A$2.53 B
Marketcap
A$24.90
Share price
-4.30%
Change (1 day)
-49.28%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2026 (TTM): A-$7.56

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is A-$7.84. In 2025 the company made an earnings per share (EPS) of A-$8.82 an increase over its 2024 EPS that were of A-$9.58.

EPS history for Ultragenyx Pharmaceutical from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$7.56-14.35%
2025A-$8.82-7.89%
2024A-$9.58-23.89%
2023A-$12.58-17.61%
2022A-$15.2750.67%
2021A-$10.14113.69%
2020A-$4.74-55.9%
2019A-$10.7682.56%
2018A-$5.89-45.15%
2017A-$10.7414.68%
2016A-$9.37
2014A-$3.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Lexicon Pharmaceuticals
LXRX
A-$0.21-97.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.03022-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.17-97.88%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A-$0.14-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA